References
- 1Chua CB, Sun CK, Hsu CW, Tai YC, Liang CY, Tsai IT. “Diabetic striatopathy”: clinical presentations, controversy, pathogenesis, treatments, and outcomes. Sci Rep. 2020; 10: 1594. DOI: 10.1038/s41598-020-58555-w
- 2Dubey S, Chatterjee S, Mukherjee D, Ghosh R, Sengupta S, Lahiri D, et al. “Dancing belly” in an old diabetic lady. J Family Med Prim Care. 2020; 9: 2580–2. DOI: 10.4103/jfmpc.jfmpc_1223_19
- 3Lozsadi D. Myoclonus: a pragmatic approach. Pract Neurol. 2012; 12: 215–24. DOI: 10.1136/practneurol-2011-000107
- 4Khan Z, Arya K, Bollu PC.
EpilepsiaPartialis Continua . 2020 Sep 4. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2020 Jan–. PMID: 30335308. - 5Iyer RS, Ramakrishnan TCR, Karunakaran, Shinto A, Kamaleshwaran KK. Faciobrachial dystonic seizures result from fronto-temporo-basalganglial network involvement. Epilepsy Behav Case Rep. 2017; 8: 47–50. DOI: 10.1016/j.ebcr.2017.06.001
- 6Morano A, Fanella M, Giallonardo AT, Di Bonaventura C. Faciobrachial Dystonic Seizures: The Borderland Between Epilepsy and Movement Disorders. Mov Disord Clin Pract. 2020; 7: 228–9. DOI: 10.1002/mdc3.12884
- 7Simabukuro MM, Nóbrega PR, Pitombeira M, Cavalcante WCP, Grativvol RS, Pinto LF, et al. The importance of recognizing faciobrachial dystonic seizures in rapidly progressive dementias. Dement Neuropsychol. 2016; 10: 351–7. DOI: 10.1590/s1980-5764-2016dn1004016
- 8Eberhardt O, Topka H. Myoclonic Disorders. Brain Sci. 2017; 7: 103. DOI: 10.3390/brainsci7080103
- 9Jagota P, Bhidayasiri R, Lang AE. Movement disorders in patients with diabetes mellitus. J Neurol Sci. 2012; 314: 5–11. DOI: 10.1016/j.jns.2011.10.033
- 10Guddati AK, Zafar Z, Cheng JT, Mohan S. Treatment of gabapentin-induced myoclonus with continuous renal replacement therapy. Indian J Nephrol. 2012; 22: 59–61. DOI: 10.4103/0971-4065.83744
- 11Serino D, Davico C, Specchio N, Marras CE, Fioretto F. Berardinelli-Seip syndrome and progressive myoclonus epilepsy. Epileptic Disord. 2019; 21: 117–21.
- 12Pegg E, Tanveer R, Lekuwwa G, Mills R, Emsley H. Diabetic polyradiculoneuropathy presenting with myoclonus. J NeurolNeurosurg Psychiatry. 2016; 87: e1. DOI: 10.1136/jnnp-2016-315106.52
- 13Zaidi SA, Chhetri SK, Lekwuwa G, Majeed T. An unusual presentation of diabetic amyotrophy: myoclonus. BMJ Case Rep. 2013; 2013: bcr2012008245. DOI: 10.1136/bcr-2012-008245
- 14Nysten C, Vanhee A, Govaerts A, Demeestere J. Ocular flutter and myoclonus in hyperosmolar hyperglycemic state. Acta Neurol Belg. 2020 Nov 10. DOI: 10.1007/s13760-020-01540-x
- 15Morres CA, Dire DJ. Movement disorders as a manifestation of nonketotic hyperglycemia. J Emerg Med. 1989; 7: 359–64. DOI: 10.1016/0736-4679(89)90306-5
- 16Ghia T, Kanhangad M, Alessandri AJ, Price G, Gera P, Nagarajan L. Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient. Pediatr Neurol. 2016; 55: 68–70. DOI: 10.1016/j.pediatrneurol.2015.09.021
- 17McKeon A, Tracy JA. GAD65 neurological autoimmunity. Muscle Nerve. 2017; 56: 15–27. DOI: 10.1002/mus.25565
- 18Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci. 2002; 23: 145–51. DOI: 10.1007/s100720200055
- 19Verrotti A, Scaparrotta A, Olivieri C, Chiarelli F. Seizures and type 1 diabetes mellitus: current state of knowledge. Eur J Endocrinol. 2012; 167: 749–58. DOI: 10.1530/EJE-12-0699
- 20Garg S, Jain P, Sharma VK, Maheshwari S. Movement Disorder - A Rare Presentation of Diabetic Ketoacidosis. J Assoc Physicians India. 2019; 67: 81–2.
- 21Awasthi D, Tiwari AK, Upadhyaya A, Singh B, Tomar GS. Ketotic hyperglycemia with movement disorder. J Emerg Trauma Shock. 2012; 5: 90–1. DOI: 10.4103/0974-2700.93095